A detailed history of Trivant Custom Portfolio Group, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Trivant Custom Portfolio Group, LLC holds 6,903 shares of ZTS stock, worth $1.22 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares
6,903
Previous 6,547 5.44%
Holding current value
$1.22 Million
Previous $1.13 Billion 18.83%
% of portfolio
0.78%
Previous 0.7%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$172.58 - $196.48 $61,438 - $69,946
356 Added 5.44%
6,903 $1.35 Billion
Q2 2024

Jul 17, 2024

BUY
$145.54 - $178.83 $938,878 - $1.15 Million
6,451 Added 6719.79%
6,547 $1.13 Billion
Q1 2023

May 19, 2023

BUY
$145.48 - $175.02 $13,966 - $16,801
96 New
96 $16 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Trivant Custom Portfolio Group, LLC Portfolio

Follow Trivant Custom Portfolio Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trivant Custom Portfolio Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trivant Custom Portfolio Group, LLC with notifications on news.